Profile - Fusion Medical Tech. Hemostatic products include devices, such as sutures, and topical agents such as sponges, used to stop bleeding. Revenues benefitted from the Company obtaining regulatory approval in the United States.
Net loss reflects higher sales and marketing expenses due to efforts to build a direct sales force.
Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Data and information is provided for informational purposes only, and is not intended for trading purposes.